Graham Fulford, founder of GFCT and GFCT Focal Therapy, was diagnosed with prostate cancer early this year. An update from Graham: My Personal Journey Continues Dear all, I mentioned in my last update that I was having a Prostatype test as part of my ongoing active surveillance and I can report that the results are now in. They indicate that I'm at low risk of mortality from prostate cancer in the next 10 years - so it's off to the pub to celebrate later! As...

A new artificial intelligence (AI) test could revolutionise prostate cancer treatment by identifying which men are most likely to benefit from abiraterone—a life-extending drug that halves the risk of death in certain patients. Abiraterone has already helped hundreds of thousands of men with advanced prostate cancer. However, access remains limited in places like England for men whose cancer has not yet spread. That could soon change, thanks to an exciting development from a team of r...

Former President Joe Biden, 82, has been diagnosed with advanced prostate cancer that has spread to his bones. Detected after he reported urinary symptoms, the cancer is aggressive (Gleason score 9), but doctors say it is hormone-sensitive and manageable. Biden and his family are reviewing treatment options. Support has poured in from across the political spectrum, including Donald Trump, Kamala Harris, and Barack Obama. Read the full BBC article - https://www.bbc.co.uk/news/artic...

Early detection saves lives – and it starts with a simple blood test. Prostate Cymru is leading an ambitious campaign across Wales to provide free or low-cost PSA tests to thousands of men, helping to catch prostate cancer early – when it's most treatable. Men often avoid testing due to outdated fears or lack of awareness. But the PSA test is quick, painless and finger-free. It's already flagged early signs of cancer in dozens of men –...

We’re proud to have been involved in the recent Prostate Cancer Conference at The Christie, jointly organised by Prostate Cancer Support (PCS) and The Graham Fulford Charitable Trust (GFCT). Our friends at South Warwickshire Prostate Cancer Support Group (SWaPS) have written a fantastic summary of the day, and we’d love to share their blog:  On May 17th, Doug Badger our Chair attended a conference, jointly organised by Prostate Cancer Support (PCS) and the Graham Fulford Ch...

New research by University of Manchester using GFCT test results data highlights the power of community-based PSA testing in prostate cancer risk detection. Article: Charity-Provided Community-Based PSA Testing for Assessment of Prostate Cancer Risk in the UK: Clinical Implications and Future Opportunities By Artitaya Lophatananon, Graham Fulford, Jon Young, Susan Hart, Matthew Brine and Kenneth R. Muir. Prostate cancer is the most common cancer in men across the UK...

We are pleased to announce that GFCT are now sponsoring a medical support service in collaboration with Dr Asif Naseem, MBBS, BSc, HONs, BCAM, MRCGP. Who is Dr Naseem? Dr Naseem is an experienced general practitioner specialising in health screening and lifestyle medicine as well as both men's and women's health. At GFCT, we are collaborating with Dr Naseem to provide high quality health and lifestyle guidance based on your test results. Why use this service?&nbs...

Hosted at The Christie Hospital, Manchester, the Prostate Cancer Support Conference, supported by GFCT, brought together patients, clinicians, and community advocates for the cause. The event aimed to empower men with knowledge to make informed choices about PSA testing and prostate cancer treatment options. The day featured a diverse programme including insights from Graham Fulford MBE on PSA testing, a moving talk by Jo Mellor from Mentell on the theme of ‘Men, is it time to talk?&r...

A remarkable night in Torquay… The Torbay Prostate Support Association’s latest PSA testing event saw a record 370 men show up, proving how community-led health initiatives are filling the gap left by the lack of a national screening programme. Of those tested, 30 received red alerts, most without symptoms. Thanks to dedicated volunteers and organisers like Ian Nightingale and Wendy Symons, these men now have a chance at early diagnosis and better outcomes.&...

Graham Fulford, founder of GFCT and GFCT Focal Therapy, was diagnosed with prostate cancer early this year. An update from Graham:  I have now received the results of my most recent PSA test, which has come back at 3.44, slightly lower than my previous result. Barring any unexpected findings from the outstanding Prostatype test, I will proceed with the next PSA test in September, followed by an MRI scan in October. Encouraging news, as you might agree! Interestingly, I arranged th...